Real-world data shows that CAR-T therapy can lower costs for patients with pre-existing comorbidities outside of the clinical setting.
Thanks to better understanding of cancer biology, the outlook for advanced lung cancer is better than it has ever been.
When it comes to fighting sarcoma, the Sarcoma Foundation of America does not stop at fundraising.
Rebecca Arend, M.D., gynecologic oncologist at University of Alabama at Birmingham Hospital, discusses the rapidly changing field of ovarian cancer.
Greg Simon, CEO of the Biden Cancer Initiative, discusses the transition from the Cancer Moonshot Initiative to the Biden Cancer Initiative.
Inflammatory breast cancer survivor, Terry Arnold, shares her story of diagnosis and survivorship.
After being diagnosed with glioblastoma, experimental immunotherapy saved his life.
A nonprofit organization aims to connect patients, caregivers and loved ones affected by sarcoma while educating those about the rare cancer.
Twenty-year-old men think they are invincible. They wake up each morning thinking that nothing can stop them and that is one of the best feelings in the world.
The National Community Oncology Dispensing Association, Inc. (NCODA) is pleased to announce the addition of Barry D. Brooks, M.D. to their Executive Council. Dr. Brooks joined the Council in April.
Elliott Winton, M.D., researcher, physician and 2016 MPN Hero, discusses some of the drastic changes that happened over the past decade or so in the world of MPNs.
Hospice care or palliative care: What's the right care for me?
A small, early trial demonstrated that a combination of Imlygic and Keytruda can have clinical benefit for patients with advanced melanoma.
After ostomies, patients must adjust to their new bodies, but can live full, active lives.
Prostate cancer survivor says acknowledging the loss of his sexuality is the first step toward getting it back.
How has the most successful cancer awareness movement become so polarizing?
Understanding the disease and treatments are key aspects of being a patient advocate, explained MPN Hero Marcy Worthington.
Real-time access to test results and doctors’ reports is putting control over health into the hands of patients.
When other therapies have failed, patients with metastatic prostate cancer who were treated with Jevtana (cabazitaxel) in the third-line setting experienced a toxicity profile similar to that of androgen-targeted therapies, making the chemotherapy agent a valid choice for some patients, according to results from the CARD trial.
Through a children’s book that describes a fanciful dream, an author/illustrator remembers a youngster lost to cancer — and raises funds to boost research.
Finalist Essay: CURE’s 2012 Extraordinary Healer Award for Oncology Nursing
I’ve spent 14 years navigating recovery, mental health challenges and giving back to the cancer community through patient mentorship.
An Extraordinary Healer essay honoring KATHY IVY, B.S.N., RN, OCN [CHILDRESS REGIONAL MEDICAL CENTER, CHILDRESS, TEXAS]
Mark Gibbons of Caregiver Action Network discusses the emotions caregivers to patients with ovarian cancer may have.